ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference

ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients

World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application

Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026

PureHealth Research Liver Health Supplements Target Fatty Liver for Improved Daily Energy

RARE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026

PMI SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Foundation for a Drug-Free World Volunteers Reach Athletes and Communities Across Italy During 2026 Winter Olympics

IBRX INVESTOR ALERT: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman

Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

Acción local para proteger a nuestra juventud de la adicción a la nicotina

Prostate Health Supplements From PureHealth Research Enhance Bladder Control With Clinical Lycopene

Local Action to Protect Our Youth from Nicotine Addiction

ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues

PureHealth Research Liver Health Herbal Supplements Deliver Milk Thistle for Optimal Enzyme Defense

ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kwench Juice Café Accelerates Nationwide Franchise Growth as Demand for Fresh, Healthy Options Surges

Kwench Juice Café's Scalable Model Attracts Multi-Unit Operators Looking to Grow in the Health Food Space

PureHealth Research Explores the Role of Turmeric and Magnesium in Its Doctor-Approved Kidney Health Supplements

The Melanoma Research Foundation Launches its Annual Denver 5K Fundraiser with a Goal of $100,000 in Support of Melanoma Research, Education and Advocacy

Meet Clicklinks: The Innovation Hub for Original Drug Discovery

ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS

SAMARITAN'S PURSE AIRLIFTS EBOLA TREATMENT CENTER TO THE DEMOCRATIC REPUBLIC OF THE CONGO

Lupin erhält Zulassung in China für Oseltamivirphosphat-Suspension zum Einnehmen